- Home
- MRK vs WFC Comparison
MRK vs WFC Comparison
Compare MRK & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | WFC |
|---|---|---|
| Founded | 2000 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | 267.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | WFC |
|---|---|---|
| Price | $102.42 | $87.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | ★ $109.64 | $89.96 |
| AVG Volume (30 Days) | ★ 14.9M | 14.0M |
| Earning Date | 10-30-2025 | 01-14-2026 |
| Dividend Yield | ★ 3.36% | 2.08% |
| EPS Growth | ★ 58.08 | 26.82 |
| EPS | ★ 7.56 | 6.07 |
| Revenue | $64,235,000,000.00 | ★ $79,072,000,000.00 |
| Revenue This Year | $1.97 | $8.81 |
| Revenue Next Year | $4.96 | $5.15 |
| P/E Ratio | ★ $13.38 | $14.22 |
| Revenue Growth | ★ 1.68 | 1.54 |
| 52 Week Low | $73.31 | $58.42 |
| 52 Week High | $105.84 | $88.64 |
Technical Indicators
Market Signals| Indicator | MRK | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 63.77 |
| Support Level | $100.31 | $85.17 |
| Resistance Level | $105.68 | $86.04 |
| Average True Range (ATR) | 3.06 | 2.03 |
| MACD | 0.52 | 0.24 |
| Stochastic Oscillator | 77.01 | 99.86 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.0 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.